303 related articles for article (PubMed ID: 6983044)
1. Glucose utilization of cerebral gliomas measured by [18F] fluorodeoxyglucose and positron emission tomography.
Di Chiro G; DeLaPaz RL; Brooks RA; Sokoloff L; Kornblith PL; Smith BH; Patronas NJ; Kufta CV; Kessler RM; Johnston GS; Manning RG; Wolf AP
Neurology; 1982 Dec; 32(12):1323-9. PubMed ID: 6983044
[TBL] [Abstract][Full Text] [Related]
2. Glucose consumption in recurrent gliomas.
Ishikawa M; Kikuchi H; Miyatake S; Oda Y; Yonekura Y; Nishizawa S
Neurosurgery; 1993 Jul; 33(1):28-33. PubMed ID: 8355844
[TBL] [Abstract][Full Text] [Related]
3. EEG, transmission computed tomography, and positron emission tomography with fluorodeoxyglucose 18F. Their use in adults with gliomas.
Newmark ME; Theodore WH; Sato S; De La Paz R; Patronas N; Brooks R; Jabbari B; Di Chiro G
Arch Neurol; 1983 Oct; 40(10):607-10. PubMed ID: 6615267
[TBL] [Abstract][Full Text] [Related]
4. Prognostic value positron emission tomography with [18F]fluoro-2-deoxy-D-glucose in the low-grade glioma.
De Witte O; Levivier M; Violon P; Salmon I; Damhaut P; Wikler D; Hildebrand J; Brotchi J; Goldman S
Neurosurgery; 1996 Sep; 39(3):470-6; discussion 476-7. PubMed ID: 8875476
[TBL] [Abstract][Full Text] [Related]
5. The in vivo metabolic pattern of low-grade brain gliomas: a positron emission tomographic study using 18F-fluorodeoxyglucose and 11C-L-methylmethionine.
Derlon JM; Petit-Taboué MC; Chapon F; Beaudouin V; Noël MH; Creveuil C; Courtheoux P; Houtteville JP
Neurosurgery; 1997 Feb; 40(2):276-87; discussion 287-8. PubMed ID: 9007859
[TBL] [Abstract][Full Text] [Related]
6. Effect of barbiturate coma on glucose utilization in normal brain versus gliomas. Positron emission tomography studies.
Blacklock JB; Oldfield EH; Di Chiro G; Tran D; Theodore W; Wright DC; Larson SM
J Neurosurg; 1987 Jul; 67(1):71-5. PubMed ID: 3496428
[TBL] [Abstract][Full Text] [Related]
7. [In vivo measurements of regional cerebral hemocirculation and metabolism in gliomas using 15O and 18F-fluorodeoxyglucose positron emission tomography].
Mineura K; Yasuda T; Kowada M; Shishido F; Ogawa T; Uemura K
No To Shinkei; 1986 Apr; 38(4):337-44. PubMed ID: 3013262
[TBL] [Abstract][Full Text] [Related]
8. In vivo disturbance of the oxidative metabolism of glucose in human cerebral gliomas.
Rhodes CG; Wise RJ; Gibbs JM; Frackowiak RS; Hatazawa J; Palmer AJ; Thomas DG; Jones T
Ann Neurol; 1983 Dec; 14(6):614-26. PubMed ID: 6606389
[TBL] [Abstract][Full Text] [Related]
9. Independent thallium-201 accumulation and fluorine-18-fluorodeoxyglucose metabolism in glioma.
Oriuchi N; Tomiyoshi K; Inoue T; Ahmad K; Sarwar M; Tokunaga M; Suzuki H; Watanabe N; Hirano T; Horikoshi S; Shibasaki T; Tamura M; Endo K
J Nucl Med; 1996 Mar; 37(3):457-62. PubMed ID: 8772644
[TBL] [Abstract][Full Text] [Related]
10. [Positron emission tomographic evaluations on hemodynamics and glucose metabolism of brain tumors and perifocal edematous tissues].
Mizukawa N; Hino A; Imahori Y; Tenjin H; Yano I; Yoshino E; Hirakawa K; Yamashita M; Oki F; Nakahashi H
No To Shinkei; 1989 Mar; 41(3):251-8. PubMed ID: 2787998
[TBL] [Abstract][Full Text] [Related]
11. Glucose consumption and rate constants for 18F-fluorodeoxyglucose in human gliomas.
Ishikawa M; Kikuchi H; Nagata I; Yamagata S; Taki W; Yonekura Y; Nishizawa S; Iwasaki Y; Mukai T
Neurol Med Chir (Tokyo); 1990 Jun; 30(6):377-81. PubMed ID: 1700316
[TBL] [Abstract][Full Text] [Related]
12. Brain imaging of glucose utilization in cerebral tumors.
Di Chiro G
Res Publ Assoc Res Nerv Ment Dis; 1985; 63():185-97. PubMed ID: 3875134
[No Abstract] [Full Text] [Related]
13. Prediction of survival in glioma patients by means of positron emission tomography.
Patronas NJ; Di Chiro G; Kufta C; Bairamian D; Kornblith PL; Simon R; Larson SM
J Neurosurg; 1985 Jun; 62(6):816-22. PubMed ID: 2987440
[TBL] [Abstract][Full Text] [Related]
14. FDG transport and phosphorylation in human gliomas measured with dynamic PET.
Herholz K; Rudolf J; Heiss WD
J Neurooncol; 1992 Feb; 12(2):159-65. PubMed ID: 1560262
[TBL] [Abstract][Full Text] [Related]
15. Identification of early recurrence of primary central nervous system tumors by [18F]fluorodeoxyglucose positron emission tomography.
Glantz MJ; Hoffman JM; Coleman RE; Friedman AH; Hanson MW; Burger PC; Herndon JE; Meisler WJ; Schold SC
Ann Neurol; 1991 Apr; 29(4):347-55. PubMed ID: 1929205
[TBL] [Abstract][Full Text] [Related]
16. In vivo imaging of glucose consumption and lactate concentration in human gliomas.
Herholz K; Heindel W; Luyten PR; denHollander JA; Pietrzyk U; Voges J; Kugel H; Friedmann G; Heiss WD
Ann Neurol; 1992 Mar; 31(3):319-27. PubMed ID: 1637139
[TBL] [Abstract][Full Text] [Related]
17. Relation between tissue nature and (18F) fluorodeoxyglucose kinetics evaluated by dynamic positron emission tomography in human brain tumors.
Yamaguchi T; Sasaki H; Ogawa T; Mineura K; Uemura K; Kanno I; Shishido F; Murakami M; Inugami A; Higano S
Acta Radiol Suppl; 1986; 369():415-8. PubMed ID: 2980513
[TBL] [Abstract][Full Text] [Related]
18. Uncoupling of hexose transport and phosphorylation in human gliomas demonstrated by PET.
Herholz K; Ziffling P; Staffen W; Pawlik G; Wagner R; Wienhard K; Heiss WD
Eur J Cancer Clin Oncol; 1988 Jul; 24(7):1139-50. PubMed ID: 3262062
[TBL] [Abstract][Full Text] [Related]
19. New grading system of cerebral gliomas using positron emission tomography with F-18 fluorodeoxyglucose.
Kim CK; Alavi JB; Alavi A; Reivich M
J Neurooncol; 1991 Feb; 10(1):85-91. PubMed ID: 2022975
[TBL] [Abstract][Full Text] [Related]
20. Regional methionine and glucose uptake in high-grade gliomas: a comparative study on PET-guided stereotactic biopsy.
Goldman S; Levivier M; Pirotte B; Brucher JM; Wikler D; Damhaut P; Dethy S; Brotchi J; Hildebrand J
J Nucl Med; 1997 Sep; 38(9):1459-62. PubMed ID: 9293808
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]